Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity.

Hilton HG, Rubinstein ND, Janki P, Ireland AT, Bernstein N, Fong NL, Wright KM, Smith M, Finkle D, Martin-McNulty B, Roy M, Imai DM, Jojic V, Buffenstein R.

PLoS Biol. 2019 Nov 21;17(11):e3000528. doi: 10.1371/journal.pbio.3000528. eCollection 2019 Nov.

2.

Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers.

Choy L, Hagenbeek TJ, Solon M, French D, Finkle D, Shelton A, Venook R, Brauer MJ, Siebel CW.

Cancer Res. 2017 Mar 15;77(6):1439-1452. doi: 10.1158/0008-5472.CAN-16-1022. Epub 2017 Jan 20.

3.

Prolonged and tunable residence time using reversible covalent kinase inhibitors.

Bradshaw JM, McFarland JM, Paavilainen VO, Bisconte A, Tam D, Phan VT, Romanov S, Finkle D, Shu J, Patel V, Ton T, Li X, Loughhead DG, Nunn PA, Karr DE, Gerritsen ME, Funk JO, Owens TD, Verner E, Brameld KA, Hill RJ, Goldstein DM, Taunton J.

Nat Chem Biol. 2015 Jul;11(7):525-31. doi: 10.1038/nchembio.1817. Epub 2015 May 25.

4.

Mapping in vivo tumor oxygenation within viable tumor by 19F-MRI and multispectral analysis.

Shi Y, Oeh J, Eastham-Anderson J, Yee S, Finkle D, Peale FV Jr, Ross J, Hedehus M, van Bruggen N, Venook R, Ross S, Sampath D, Carano RA.

Neoplasia. 2013 Nov;15(11):1241-50.

5.

Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors.

Chung AS, Kowanetz M, Wu X, Zhuang G, Ngu H, Finkle D, Komuves L, Peale F, Ferrara N.

J Pathol. 2012 Aug;227(4):404-16. doi: 10.1002/path.4052. Epub 2012 Jul 3.

PMID:
22611017
6.

Therapeutic antibody targeting of individual Notch receptors.

Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, Finkle D, Venook R, Wu X, Ridgway J, Schahin-Reed D, Dow GJ, Shelton A, Stawicki S, Watts RJ, Zhang J, Choy R, Howard P, Kadyk L, Yan M, Zha J, Callahan CA, Hymowitz SG, Siebel CW.

Nature. 2010 Apr 15;464(7291):1052-7. doi: 10.1038/nature08878.

PMID:
20393564
7.

HER2-targeted therapy reduces incidence and progression of midlife mammary tumors in female murine mammary tumor virus huHER2-transgenic mice.

Finkle D, Quan ZR, Asghari V, Kloss J, Ghaboosi N, Mai E, Wong WL, Hollingshead P, Schwall R, Koeppen H, Erickson S.

Clin Cancer Res. 2004 Apr 1;10(7):2499-511.

8.

In vivo effects of cardiotrophin-1.

Jin H, Yang R, Keller GA, Ryan A, Ko A, Finkle D, Swanson TA, Li W, Pennica D, Wood WI, Paoni NF.

Cytokine. 1996 Dec;8(12):920-6.

PMID:
9050750
9.

Training volunteers to deliver a breast health programme.

Kisby M, Finkle D, Hill C.

J Volunt Adm. 1995 Summer;13(4):22-7. No abstract available.

PMID:
10145145
10.

Comparison of the diagnostic methods used in maxillofacial trauma.

Finkle DR, Ringler SL, Luttenton CR, Beernink JH, Peterson NT, Dean RE.

Plast Reconstr Surg. 1985 Jan;75(1):32-41.

PMID:
3966105
11.

CAT scan for facial fractures.

Finkle DR.

Plast Reconstr Surg. 1983 Jul;72(1):112-3. No abstract available.

PMID:
6867170
12.

Buffered hydrochloric acid: a modern method of treating metabolic alkalosis.

Finkle D, Dean RE.

Am Surg. 1981 Mar;47(3):103-6.

PMID:
6782923

Supplemental Content

Loading ...
Support Center